Pertuzumab and Trastuzumab hyaluronidase (Phesgo)
Jump to navigation
Jump to search
General information
A combination of pertuzumab and trastuzumab, to be given by subcutaneous injection
History of changes in FDA indication
- 6/29/2020: Initial FDA approval
History of changes in EMA indication
- 12/21/2020: Initial authorization
Also known as
- Generic name: pertuzumab/trastuzumab/hyaluronidase-zzxf
- Brand name: Phesgo